1. Home
  2. SYF vs ILMN Comparison

SYF vs ILMN Comparison

Compare SYF & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SYF

Synchrony Financial

HOLD

Current Price

$75.46

Market Cap

25.5B

Sector

Finance

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$162.26

Market Cap

24.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYF
ILMN
Founded
1932
1998
Country
United States
United States
Employees
20000
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5B
24.6B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
SYF
ILMN
Price
$75.46
$162.26
Analyst Decision
Buy
Hold
Analyst Count
19
17
Target Price
$84.83
$124.24
AVG Volume (30 Days)
3.2M
1.7M
Earning Date
04-21-2026
04-30-2026
Dividend Yield
1.60%
N/A
EPS Growth
N/A
170.87
EPS
N/A
0.87
Revenue
N/A
$4,343,000,000.00
Revenue This Year
$84.92
$6.47
Revenue Next Year
$5.11
$5.58
P/E Ratio
$7.85
$185.16
Revenue Growth
N/A
N/A
52 Week Low
$63.08
$88.00
52 Week High
$88.77
$177.22

Technical Indicators

Market Signals
Indicator
SYF
ILMN
Relative Strength Index (RSI) 59.25 56.82
Support Level $74.95 $155.55
Resistance Level $75.47 $177.22
Average True Range (ATR) 2.12 6.68
MACD 0.55 -1.01
Stochastic Oscillator 81.08 29.44

Price Performance

Historical Comparison
SYF
ILMN

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: